PRELUDE CAPITAL MANAGEMENT, LLC - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 99 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$1,364,000
+22633.3%
57,057
+12867.5%
0.04%
Q2 2020$6,000
+50.0%
440
-46.9%
0.00%
Q4 2019$4,000
-33.3%
828
-14.8%
0.00%
Q3 2019$6,000
-64.7%
972
-63.0%
0.00%
-100.0%
Q2 2019$17,000
+41.7%
2,626
+60.3%
0.00%0.0%
Q1 2019$12,000
+33.3%
1,638
-11.0%
0.00%0.0%
Q4 2018$9,000
-35.7%
1,840
-1.3%
0.00%0.0%
Q3 2018$14,000
-22.2%
1,865
-42.6%
0.00%0.0%
Q1 2018$18,000
+500.0%
3,248
+364.0%
0.00%
Q4 2017$3,0007000.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders